Last reviewed · How we verify

NCT07067645: vagina

Post-Hysterectomy Vaginal Length: Horizontal vs. Vertical Closure

Recruiting now NA Last updated 16 July 2025
What this trial tests

NA trial testing Horizontal Vaginal Cuff Closure Technique in Prolapse, Vaginal in 62 participants. Currently enrolling.

Timeline
1 July 2025
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment62
Start date1 July 2025
Primary completion1 January 2026
Estimated completion1 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 35 to 65, female only, with Prolapse, Vaginal or Vaginal Vault Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective clinical study aims to evaluate the impact of vaginal cuff closure orientation-horizontal versus vertical-on postoperative total vaginal length in patients undergoing vaginal hysterectomy combined with lateral suspension. By comparing anatomical outcomes between the two closure techniques, the study seeks to determine which method better preserves vaginal length, potentially influencing surgical preferences and postoperative quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prolapse, Vaginal

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07067645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing